Sansone Christopher R. 4
4 · InfuSystem Holdings, Inc · Filed Nov 21, 2022
Insider Transaction Report
Form 4
Sansone Christopher R.
Director
Transactions
- Sale
Common Stock
2022-11-21$8.06/sh−40,000$322,400→ 147,280 total(indirect: See) - Sale
Common Stock
2022-11-17$8.19/sh−40,838$334,463→ 187,280 total(indirect: See)
Holdings
- 25,000
Common Stock
- 1,464,916(indirect: See)
Common Stock
Footnotes (2)
- [F1]The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.